Full View

Non–vitamin K antagonist oral anticoagulants for stroke prevention in Asian patients with nonvalvular atrial fibrillation: meta-analysis

KL Wang, GYH Lip, SJ Lin, CE Chiang - Stroke, 2015 - Am Heart Assoc
Background and Purpose—The use of vitamin K antagonists (VKAs), the cornerstone
treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived …
被引用次数：224 相关文章

Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation: Meta-Analysis

KL Wang, GYH Lip, SJ Lin, CE Chiang - Stroke, 2015 - vbn.aau.dk
BACKGROUND AND PURPOSE: The use of vitamin K antagonists (VKAs), the cornerstone
treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived …

Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation: Meta-Analysis

KL Wang, GYH Lip, SJ Lin, CE Chiang - Stroke, 2015 - pubmed.ncbi.nlm.nih.gov
Background and purpose The use of vitamin K antagonists (VKAs), the cornerstone
treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived …
[PDF] medtrib.cn

[PDF][PDF] Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation

KL Wang, GYH Lip, SJ Lin, CE Chiang - Stroke, 2015 - file.medtrib.cn
Background and Purpose—The use of vitamin K antagonists (VKAs), the cornerstone
treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived …

Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation: Meta-Analysis.

KL Wang, GY Lip, SJ Lin, CE Chiang - Stroke, 2015 - europepmc.org
Background and purpose The use of vitamin K antagonists (VKAs), the cornerstone
treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived …

Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation

KL Wang, GYH Lip, SJ Lin, CE Chiang - Stroke, 2015 - Am Heart Assoc
Background and Purpose—The use of vitamin K antagonists (VKAs), the cornerstone
treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived …

Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation

KL Wang, GYH Lip, SJ Lin, CE Chiang - Stroke, 2015 - ingentaconnect.com
Background and Purpose—The use of vitamin K antagonists (VKAs), the cornerstone
treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived …
[PDF] psu.edu

[PDF][PDF] Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation

KL Wang, GYH Lip, SJ Lin, CE Chiang - Stroke, 2015 - Citeseer
Background and Purpose—The use of vitamin K antagonists (VKAs), the cornerstone
treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived …
[HTML] nih.gov

[HTML][HTML] Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation: Meta-Analysis

KL Wang, GYH Lip, SJ Lin… - Stroke; a Journal of …, 2015 - ncbi.nlm.nih.gov
Background and Purpose—The use of vitamin K antagonists (VKAs), the cornerstone
treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived …

Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation

KL Wang, GYH Lip, SJ Lin, CE Chiang - Stroke, 2015 - cir.nii.ac.jp
< jats: sec>< jats: title> Background and Purpose—</jats: title>< jats: p> The use of vitamin K
antagonists (VKAs), the cornerstone treatment for stroke prevention in patients with atrial …